KNSA icon

Kiniksa Pharmaceuticals
KNSA

Overview Fund Activity

103 hedge funds and large institutions have $346M invested in Kiniksa Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 41 increasing their positions, 27 reducing their positions, and 20 closing their positions.

Holders
103
Holders Change
+2
Holders Change %
+1.98%
% of All Funds
1.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
41
Reduced
27
Closed
20
Calls
$3.67M
Puts
$2.79M
Net Calls
+$874K
Net Calls Change
+$1.26M

Top Buyers

1
BlackRock
1
BlackRock
New York
$41M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$3.57M
3
Millennium Management
3
Millennium Management
New York
$6.21M
4
ECM
4
Endurant Capital Management
California
$2.87M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$34M

Top Sellers

1
State Street
1
State Street
Massachusetts
$17.2M
2
LPC
2
Lion Point Capital
New York
$647K
3
OM
3
Opaleye Management
Massachusetts
$12.1M
4
BC
4
Boxer Capital
California
$0
5
WP
5
Woodline Partners
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
AWA
126
Amplius Wealth Advisors
Pennsylvania
$0 35 +35 New
2 3 4 5
6